Clinical Trial Update: Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects [Phase 4]

View source ↗

Summary

Phase 4 trial results assess mitochondrial effects when switching HIV patients from Combivir or Trizivir to Truvada, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
• Trizivir

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2013-03-04